Trial intelligence / Profile preview

Articaine versus lidocaine effects on blood pressure after maxillary infiltration

IRCT20200724048188N1Phase 2Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Oct 2020
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, triple-blind trial of articaine, lidocaine and epinephrine (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Systolic blood pressure and Diastolic blood pressure. Started Oct 2020; status: completed.

02

Drugs

articainelidocaineepinephrine

Beyond the preview

Go deeper on IRCT20200724048188N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200724048188N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call